Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Balavenkatraman KK"'
Autor:
Richards SM; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Gubser Keller C; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Kreutzer R; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Department of Pathology, AnaPath Services GmbH, Liestal, Switzerland., Greiner G; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Ley S; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Doelemeyer A; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Dubost V; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Flandre T; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Kirkland S; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Harvantis Pharma Consulting Ltd, London, UK., Carbone W; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Research and Development Coordinator, ELI TechGroup Corso Svizzera, Torino, Italy., Pandya R; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Knehr J; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Roma G; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Discovery Data Science, GSK Vaccines, Siena, Italy., Schuierer S; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Bouchez L; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Therapeutics Department, Executive in Residence, General Inception, Basel, Switzerland., Seuwen K; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Aebi A; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Westhead D; Leeds Institute of Data Analytics, University of Leeds, Leeds, UK., Hintzen G; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Translational Science, Affimed GmbH, Mannheim, Germany., Jurisic G; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Hossain I; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Neri M; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Manevski N; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Translational PKPD and Clinical Pharmacology, Pharmaceutical Sciences, pRED, F. Hoffmann-La Roche AG, Basel, Switzerland., Balavenkatraman KK; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Moulin P; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Begrich A; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Bertschi B; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Huber R; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Bouwmeester T; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Driver VR; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; INOVA Healthcare, Wound Healing and Hyperbaric Centers, Falls Church, Virginia, USA., von Schwabedissen M; Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Basel, Switzerland., Schaefer D; Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Basel, Switzerland., Wettstein B; Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Basel, Switzerland., Wettstein R; Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Basel, Switzerland., Ruffner H; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.
Publikováno v:
International wound journal [Int Wound J] 2024 Apr; Vol. 21 (4), pp. e14447. Date of Electronic Publication: 2023 Dec 27.
Autor:
Rothenberger S; Spiez Laboratory, Austrasse, Spiez, Switzerland.; Institute of Microbiology, University Hospital Center and University of Lausanne, Lausanne, Switzerland., Hurdiss DL; Department Biomolecular Health Sciences, Division Infectious Diseases & Immunology - Virology section, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands.; Cryo-Electron Microscopy, Bijvoet Center for Biomolecular Research, Department of Chemistry, Faculty of Science, Utrecht University, Utrecht, Netherlands., Walser M; Molecular Partners AG, Zurich-Schlieren, Switzerland., Malvezzi F; Molecular Partners AG, Zurich-Schlieren, Switzerland., Mayor J; Spiez Laboratory, Austrasse, Spiez, Switzerland.; Institute of Microbiology, University Hospital Center and University of Lausanne, Lausanne, Switzerland., Ryter S; Spiez Laboratory, Austrasse, Spiez, Switzerland., Moreno H; Institute of Microbiology, University Hospital Center and University of Lausanne, Lausanne, Switzerland., Liechti N; Spiez Laboratory, Austrasse, Spiez, Switzerland., Bosshart A; Molecular Partners AG, Zurich-Schlieren, Switzerland., Iss C; Molecular Partners AG, Zurich-Schlieren, Switzerland., Calabro V; Molecular Partners AG, Zurich-Schlieren, Switzerland., Cornelius A; Molecular Partners AG, Zurich-Schlieren, Switzerland., Hospodarsch T; Molecular Partners AG, Zurich-Schlieren, Switzerland., Neculcea A; Molecular Partners AG, Zurich-Schlieren, Switzerland., Looser T; Molecular Partners AG, Zurich-Schlieren, Switzerland., Schlegel A; Molecular Partners AG, Zurich-Schlieren, Switzerland., Fontaine S; Molecular Partners AG, Zurich-Schlieren, Switzerland., Villemagne D; Molecular Partners AG, Zurich-Schlieren, Switzerland., Paladino M; Molecular Partners AG, Zurich-Schlieren, Switzerland., Schiegg D; Molecular Partners AG, Zurich-Schlieren, Switzerland., Mangold S; Molecular Partners AG, Zurich-Schlieren, Switzerland., Reichen C; Molecular Partners AG, Zurich-Schlieren, Switzerland., Radom F; Molecular Partners AG, Zurich-Schlieren, Switzerland., Kaufmann Y; Molecular Partners AG, Zurich-Schlieren, Switzerland., Schaible D; Molecular Partners AG, Zurich-Schlieren, Switzerland., Schlegel I; Molecular Partners AG, Zurich-Schlieren, Switzerland., Zitt C; Molecular Partners AG, Zurich-Schlieren, Switzerland., Sigrist G; Molecular Partners AG, Zurich-Schlieren, Switzerland., Straumann M; Molecular Partners AG, Zurich-Schlieren, Switzerland., Wolter J; Molecular Partners AG, Zurich-Schlieren, Switzerland., Comby M; Molecular Partners AG, Zurich-Schlieren, Switzerland., Sacarcelik F; Molecular Partners AG, Zurich-Schlieren, Switzerland., Drulyte I; Materials and Structural Analysis, Thermo Fisher Scientific, Eindhoven, Netherlands., Lyoo H; Department Biomolecular Health Sciences, Division Infectious Diseases & Immunology - Virology section, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands., Wang C; Department Biomolecular Health Sciences, Division Infectious Diseases & Immunology - Virology section, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands., Li W; Department Biomolecular Health Sciences, Division Infectious Diseases & Immunology - Virology section, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands., Du W; Department Biomolecular Health Sciences, Division Infectious Diseases & Immunology - Virology section, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands., Binz HK; Binz Biotech Consulting, Zug, Switzerland., Herrup R; Laboratory of Immunoregulation, Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Lusvarghi S; Laboratory of Immunoregulation, Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Neerukonda SN; Laboratory of Immunoregulation, Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Vassell R; Laboratory of Immunoregulation, Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Wang W; Laboratory of Immunoregulation, Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Adler JM; Freie Universität Berlin, Institut für Virologie, Berlin, Germany., Eschke K; Freie Universität Berlin, Institut für Virologie, Berlin, Germany., Nascimento M; Freie Universität Berlin, Institut für Virologie, Berlin, Germany., Abdelgawad A; Freie Universität Berlin, Institut für Virologie, Berlin, Germany., Gruber AD; Freie Universität Berlin, Institut für Tierpathologie, Berlin, Germany., Bushe J; Freie Universität Berlin, Institut für Tierpathologie, Berlin, Germany., Kershaw O; Freie Universität Berlin, Institut für Tierpathologie, Berlin, Germany., Knutson CG; Novartis Institutes for BioMedical Research, PK Sciences, Cambridge, MA, USA., Balavenkatraman KK; Novartis Institutes for BioMedical Research, Preclinical Safety, Basel, Switzerland., Ramanathan K; Novartis Pharma AG, Basel, Switzerland., Wyler E; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Teixeira Alves LG; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Lewis S; Molecular Partners AG, Zurich-Schlieren, Switzerland., Watson R; Molecular Partners AG, Zurich-Schlieren, Switzerland., Haeuptle MA; Molecular Partners AG, Zurich-Schlieren, Switzerland., Zürcher A; Molecular Partners AG, Zurich-Schlieren, Switzerland., Dawson KM; Molecular Partners AG, Zurich-Schlieren, Switzerland., Steiner D; Molecular Partners AG, Zurich-Schlieren, Switzerland., Weiss CD; Laboratory of Immunoregulation, Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Amstutz P; Molecular Partners AG, Zurich-Schlieren, Switzerland., van Kuppeveld FJM; Department Biomolecular Health Sciences, Division Infectious Diseases & Immunology - Virology section, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands., Stumpp MT; Molecular Partners AG, Zurich-Schlieren, Switzerland. info@molecularpartners.com., Bosch BJ; Department Biomolecular Health Sciences, Division Infectious Diseases & Immunology - Virology section, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands., Engler O; Spiez Laboratory, Austrasse, Spiez, Switzerland., Trimpert J; Freie Universität Berlin, Institut für Virologie, Berlin, Germany.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2022 Dec; Vol. 40 (12), pp. 1845-1854. Date of Electronic Publication: 2022 Jul 21.
Autor:
Shimshek DR; Neuroscience, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Jacobson LH; Neuroscience, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Kolly C; Preclinical Safety, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Zamurovic N; Preclinical Safety, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Balavenkatraman KK; Preclinical Safety, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Morawiec L; Preclinical Safety, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Kreutzer R; Preclinical Safety, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Schelle J; Department of Cellular Neurology, Hertie-Institute for Clinical Brain Research, University of Tübingen and German Center for Neurodegenerative Diseases (DZNE), 72076 Tübingen, Germany., Jucker M; Department of Cellular Neurology, Hertie-Institute for Clinical Brain Research, University of Tübingen and German Center for Neurodegenerative Diseases (DZNE), 72076 Tübingen, Germany., Bertschi B; Preclinical Safety, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Theil D; Preclinical Safety, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Heier A; Preclinical Safety, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Bigot K; Preclinical Safety, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Beltz K; Metabolism and Pharmacokinetics, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Machauer R; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Brzak I; Neuroscience, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Perrot L; Neuroscience, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Neumann U; Neuroscience, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland.
Publikováno v:
Scientific reports [Sci Rep] 2016 Feb 25; Vol. 6, pp. 21917. Date of Electronic Publication: 2016 Feb 25.
Autor:
Manevski N; Drug Metabolism and Pharmacokinetics (N.M., P.S., G.C., O.K., H.S., M.W., K.L.), Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), and Clinical Sciences and Innovation Translational Medicine (J.A.-C.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery (B.L., R.W., D.J.S.), and Department of Dermatology (P.I.), University Hospital Basel, Basel, Switzerland., Swart P; Drug Metabolism and Pharmacokinetics (N.M., P.S., G.C., O.K., H.S., M.W., K.L.), Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), and Clinical Sciences and Innovation Translational Medicine (J.A.-C.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery (B.L., R.W., D.J.S.), and Department of Dermatology (P.I.), University Hospital Basel, Basel, Switzerland., Balavenkatraman KK; Drug Metabolism and Pharmacokinetics (N.M., P.S., G.C., O.K., H.S., M.W., K.L.), Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), and Clinical Sciences and Innovation Translational Medicine (J.A.-C.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery (B.L., R.W., D.J.S.), and Department of Dermatology (P.I.), University Hospital Basel, Basel, Switzerland., Bertschi B; Drug Metabolism and Pharmacokinetics (N.M., P.S., G.C., O.K., H.S., M.W., K.L.), Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), and Clinical Sciences and Innovation Translational Medicine (J.A.-C.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery (B.L., R.W., D.J.S.), and Department of Dermatology (P.I.), University Hospital Basel, Basel, Switzerland., Camenisch G; Drug Metabolism and Pharmacokinetics (N.M., P.S., G.C., O.K., H.S., M.W., K.L.), Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), and Clinical Sciences and Innovation Translational Medicine (J.A.-C.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery (B.L., R.W., D.J.S.), and Department of Dermatology (P.I.), University Hospital Basel, Basel, Switzerland., Kretz O; Drug Metabolism and Pharmacokinetics (N.M., P.S., G.C., O.K., H.S., M.W., K.L.), Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), and Clinical Sciences and Innovation Translational Medicine (J.A.-C.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery (B.L., R.W., D.J.S.), and Department of Dermatology (P.I.), University Hospital Basel, Basel, Switzerland., Schiller H; Drug Metabolism and Pharmacokinetics (N.M., P.S., G.C., O.K., H.S., M.W., K.L.), Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), and Clinical Sciences and Innovation Translational Medicine (J.A.-C.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery (B.L., R.W., D.J.S.), and Department of Dermatology (P.I.), University Hospital Basel, Basel, Switzerland., Walles M; Drug Metabolism and Pharmacokinetics (N.M., P.S., G.C., O.K., H.S., M.W., K.L.), Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), and Clinical Sciences and Innovation Translational Medicine (J.A.-C.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery (B.L., R.W., D.J.S.), and Department of Dermatology (P.I.), University Hospital Basel, Basel, Switzerland., Ling B; Drug Metabolism and Pharmacokinetics (N.M., P.S., G.C., O.K., H.S., M.W., K.L.), Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), and Clinical Sciences and Innovation Translational Medicine (J.A.-C.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery (B.L., R.W., D.J.S.), and Department of Dermatology (P.I.), University Hospital Basel, Basel, Switzerland., Wettstein R; Drug Metabolism and Pharmacokinetics (N.M., P.S., G.C., O.K., H.S., M.W., K.L.), Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), and Clinical Sciences and Innovation Translational Medicine (J.A.-C.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery (B.L., R.W., D.J.S.), and Department of Dermatology (P.I.), University Hospital Basel, Basel, Switzerland., Schaefer DJ; Drug Metabolism and Pharmacokinetics (N.M., P.S., G.C., O.K., H.S., M.W., K.L.), Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), and Clinical Sciences and Innovation Translational Medicine (J.A.-C.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery (B.L., R.W., D.J.S.), and Department of Dermatology (P.I.), University Hospital Basel, Basel, Switzerland., Itin P; Drug Metabolism and Pharmacokinetics (N.M., P.S., G.C., O.K., H.S., M.W., K.L.), Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), and Clinical Sciences and Innovation Translational Medicine (J.A.-C.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery (B.L., R.W., D.J.S.), and Department of Dermatology (P.I.), University Hospital Basel, Basel, Switzerland., Ashton-Chess J; Drug Metabolism and Pharmacokinetics (N.M., P.S., G.C., O.K., H.S., M.W., K.L.), Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), and Clinical Sciences and Innovation Translational Medicine (J.A.-C.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery (B.L., R.W., D.J.S.), and Department of Dermatology (P.I.), University Hospital Basel, Basel, Switzerland., Pognan F; Drug Metabolism and Pharmacokinetics (N.M., P.S., G.C., O.K., H.S., M.W., K.L.), Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), and Clinical Sciences and Innovation Translational Medicine (J.A.-C.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery (B.L., R.W., D.J.S.), and Department of Dermatology (P.I.), University Hospital Basel, Basel, Switzerland., Wolf A; Drug Metabolism and Pharmacokinetics (N.M., P.S., G.C., O.K., H.S., M.W., K.L.), Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), and Clinical Sciences and Innovation Translational Medicine (J.A.-C.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery (B.L., R.W., D.J.S.), and Department of Dermatology (P.I.), University Hospital Basel, Basel, Switzerland., Litherland K; Drug Metabolism and Pharmacokinetics (N.M., P.S., G.C., O.K., H.S., M.W., K.L.), Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), and Clinical Sciences and Innovation Translational Medicine (J.A.-C.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery (B.L., R.W., D.J.S.), and Department of Dermatology (P.I.), University Hospital Basel, Basel, Switzerland Karine.Litherland@novartis.com.
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2015 Jan; Vol. 43 (1), pp. 126-39. Date of Electronic Publication: 2014 Oct 22.
Autor:
Manevski N; Drug Metabolism and Pharmacokinetics (N.M., P.S., M.W., G.C., H.S., O.K., K.L.) and Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Basel, Switzerland (B.L., R.W., D.J.S.)., Balavenkatraman KK; Drug Metabolism and Pharmacokinetics (N.M., P.S., M.W., G.C., H.S., O.K., K.L.) and Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Basel, Switzerland (B.L., R.W., D.J.S.)., Bertschi B; Drug Metabolism and Pharmacokinetics (N.M., P.S., M.W., G.C., H.S., O.K., K.L.) and Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Basel, Switzerland (B.L., R.W., D.J.S.)., Swart P; Drug Metabolism and Pharmacokinetics (N.M., P.S., M.W., G.C., H.S., O.K., K.L.) and Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Basel, Switzerland (B.L., R.W., D.J.S.)., Walles M; Drug Metabolism and Pharmacokinetics (N.M., P.S., M.W., G.C., H.S., O.K., K.L.) and Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Basel, Switzerland (B.L., R.W., D.J.S.)., Camenisch G; Drug Metabolism and Pharmacokinetics (N.M., P.S., M.W., G.C., H.S., O.K., K.L.) and Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Basel, Switzerland (B.L., R.W., D.J.S.)., Schiller H; Drug Metabolism and Pharmacokinetics (N.M., P.S., M.W., G.C., H.S., O.K., K.L.) and Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Basel, Switzerland (B.L., R.W., D.J.S.)., Kretz O; Drug Metabolism and Pharmacokinetics (N.M., P.S., M.W., G.C., H.S., O.K., K.L.) and Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Basel, Switzerland (B.L., R.W., D.J.S.)., Ling B; Drug Metabolism and Pharmacokinetics (N.M., P.S., M.W., G.C., H.S., O.K., K.L.) and Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Basel, Switzerland (B.L., R.W., D.J.S.)., Wettstein R; Drug Metabolism and Pharmacokinetics (N.M., P.S., M.W., G.C., H.S., O.K., K.L.) and Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Basel, Switzerland (B.L., R.W., D.J.S.)., Schaefer DJ; Drug Metabolism and Pharmacokinetics (N.M., P.S., M.W., G.C., H.S., O.K., K.L.) and Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Basel, Switzerland (B.L., R.W., D.J.S.)., Pognan F; Drug Metabolism and Pharmacokinetics (N.M., P.S., M.W., G.C., H.S., O.K., K.L.) and Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Basel, Switzerland (B.L., R.W., D.J.S.)., Wolf A; Drug Metabolism and Pharmacokinetics (N.M., P.S., M.W., G.C., H.S., O.K., K.L.) and Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Basel, Switzerland (B.L., R.W., D.J.S.)., Litherland K; Drug Metabolism and Pharmacokinetics (N.M., P.S., M.W., G.C., H.S., O.K., K.L.) and Pre-clinical Safety (K.K.B., B.B., F.P., A.W.), Novartis Institutes for BioMedical Research, Novartis Pharma, Basel, Switzerland; and Department of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Basel, Switzerland (B.L., R.W., D.J.S.) Karine.Litherland@novartis.com.
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2014 Dec; Vol. 42 (12), pp. 2049-57. Date of Electronic Publication: 2014 Sep 23.
Autor:
Balavenkatraman KK; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland., Aceto N, Britschgi A, Mueller U, Bence KK, Neel BG, Bentires-Alj M
Publikováno v:
Molecular cancer research : MCR [Mol Cancer Res] 2011 Oct; Vol. 9 (10), pp. 1377-84. Date of Electronic Publication: 2011 Aug 17.
Autor:
Petermann A; Institute of Molecular Cell Biology, Center for Molecular Biomedicine, Jena, Germany., Haase D, Wetzel A, Balavenkatraman KK, Tenev T, Gührs KH, Friedrich S, Nakamura M, Mawrin C, Böhmer FD
Publikováno v:
Brain pathology (Zurich, Switzerland) [Brain Pathol] 2011 Jul; Vol. 21 (4), pp. 405-18. Date of Electronic Publication: 2010 Dec 27.
Autor:
Veeriah S; Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. veeriahs@mskcc.org, Balavenkatraman KK, Böhmer F, Kahle K, Glei M, Richling E, Scheppach W, Pool-Zobel BL
Publikováno v:
European journal of nutrition [Eur J Nutr] 2008 Aug; Vol. 47 (5), pp. 226-34. Date of Electronic Publication: 2008 Jul 17.
Autor:
Kern M; Institute of Applied Biosciences, Section of Food Toxicology, University of Karlsruhe TH, Adenauerring 20, 76131 Karlsruhe, Germany., Pahlke G, Balavenkatraman KK, Böhmer FD, Marko D
Publikováno v:
Journal of agricultural and food chemistry [J Agric Food Chem] 2007 Jun 27; Vol. 55 (13), pp. 4999-5006. Date of Electronic Publication: 2007 Jun 02.
Autor:
Balavenkatraman KK; Institute of Molecular Cell Biology, Medical Faculty, Friedrich Schiller University, Jena, Germany., Jandt E, Friedrich K, Kautenburger T, Pool-Zobel BL, Ostman A, Böhmer FD
Publikováno v:
Oncogene [Oncogene] 2006 Oct 12; Vol. 25 (47), pp. 6319-24. Date of Electronic Publication: 2006 May 08.